The regulation mechanism of the CB2 receptor is changed in endometrial cancer because of a significant increase in the level of CB2 in the cell line of human endometrial carcinoma (AN3CA) compared to healthy cells. This evidence concerns the gene CNR2 and endometrial carcinoma.